Search

everythinglearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

LC-OCT helps accurately diagnose different types of infant hair loss without invasive methods.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Glehnia littoralis and Andrographis paniculata extracts can significantly boost hair growth.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Human scalp hair follicles can produce hormones and have a system similar to a brain-body communication network.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Alopecia areata treatment varies, with no optimal method established yet.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.